# Drug metadata mapping (YAML)
#
# Keys can be:
#   - Exact URL of a source page
#   - Exact filename (e.g., a local PDF basename)
#   - A substring that appears in URL, filename, or title
# Values must contain:
#   - drug_name: string
#   - active_ingridients: list of strings
#
# Notes:
# - Field name is intentionally spelled "active_ingridients" to match the code.
# - First matching key is used in order of priority: exact URL, exact filename, then substring.

##### Diabetes - DPP-4 Inhibitors #####

"CP-2011-PI-03485-3.pdf":
  drug_name: "Trajenta"
  active_ingridients: ["Linagliptin"]

"CP-2011-CMI-03486-3.pdf":
  drug_name: "Trajenta"
  active_ingridients: ["Linagliptin"]

#####

"CP-2010-PI-03937-3.pdf":
  drug_name: "Januvia"
  active_ingridients: ["Sitagliptin phosphate monohydrate"]

"CP-2010-CMI-03938-3.pdf":
  drug_name: "Januvia"
  active_ingridients: ["Sitagliptin phosphate monohydrate"]

#####

"CP-2011-PI-02123-3.pdf":
  drug_name: "Onglyza"
  active_ingridients: ["Saxagliptin hydrochloride"]

"CP-2014-CMI-02150-1.pdf":
  drug_name: "Onglyza"
  active_ingridients: ["Saxagliptin hydrochloride"]

#####

"CP-2010-PI-07768-3.pdf":
  drug_name: "Galvus"
  active_ingridients: ["Vildagliptin"]

"CP-2010-CMI-03823-3.pdf":
  drug_name: "Galvus"
  active_ingridients: ["Vildagliptin"]

#####

"CP-2013-PI-02235-1.pdf":
  drug_name: "Nesina"
  active_ingridients: ["Alogliptin benzoate"]

"CP-2013-CMI-02333-1.pdf":
  drug_name: "Nesina"
  active_ingridients: ["Alogliptin benzoate"]

##### Diabetes - SGLT2 Inhibitors #####

"CP-2014-CMI-03399-1.pdf":
  drug_name: "Jardiance"
  active_ingridients: ["Empagliflozin"]

"CP-2014-PI-01783-1.pdf":
  drug_name: "Jardiance"
  active_ingridients: ["Empagliflozin"]

#####

"CP-2016-CMI-01043-1.pdf":
  drug_name: "Jardiamet"
  active_ingridients: ["Empagliflozin", "Metformin hydrochloride"]

"CP-2015-PI-02229-1.pdf":
  drug_name: "Jardiamet"
  active_ingridients: ["Empagliflozin", "Metformin hydrochloride"]

######

"CP-2012-PI-02861-1.pdf":
  drug_name: "Forxiga"
  active_ingridients: ["Dapagliflozin propanediol monohydrate"]

"CP-2013-CMI-01654-1.pdf":
  drug_name: "Forxiga"
  active_ingridients: ["Dapagliflozin propanediol monohydrate"]

##### DPP-4 Inhibitors + SGLT2 Inhibitors #####

"CP-2018-CMI-01336-1.pdf":
  drug_name: "Glyxambi"
  active_ingridients: ["Empagliflozin", "Linagliptin"]

"CP-2017-PI-01012-1.pdf":
  drug_name: "Glyxambi"
  active_ingridients: ["Empagliflozin", "Linagliptin"]

#####

"CP-2016-PI-02701-1.pdf":
  drug_name: "Qtern"
  active_ingridients: ["Saxagliptin hydrochloride", "Dapagliflozin propanediol monohydrate"]

"CP-2018-CMI-01373-1.pdf":
  drug_name: "Qtern"
  active_ingridients: ["Saxagliptin hydrochloride", "Dapagliflozin propanediol monohydrate"]

##### GLP-1 Receptor Agonists #####

"CP-2020-CMI-01750-1.pdf":
  drug_name: "Ozempic"
  active_ingridients: ["Semaglutide"]

"CP-2019-PI-01881-1.pdf":
  drug_name: "Ozempic"
  active_ingridients: ["Semaglutide"]

#####

"CP-2024-CMI-02192-1.pdf":
  drug_name: "Wegovy"
  active_ingridients: ["Semaglutide"]

"CP-2022-PI-01930-1.pdf":
  drug_name: "Wegovy"
  active_ingridients: ["Semaglutide"]

#####

"CP-2015-PI-01412-1.pdf":
  drug_name: "Trulicity"
  active_ingridients: ["Dulaglutide (rch)"]

"CP-2018-CMI-01316-1.pdf":
  drug_name: "Trulicity"
  active_ingridients: ["Dulaglutide (rch)"]

#####

"CP-2012-CMI-02303-3.pdf":
  drug_name: "Victoza"
  active_ingridients: ["Liraglutide"]

#####

"CP-2016-PI-01008-1.pdf":
  drug_name: "Saxenda"
  active_ingridients: ["Liraglutide (rys)"]

"CP-2016-CMI-01009-1.pdf":
  drug_name: "Saxenda"
  active_ingridients: ["Liraglutide (rys)"]

#####

"CP-2023-PI-02114-1.pdf":
  drug_name: "Mounjaro"
  active_ingridients: ["Tirzepatide"]

"CP-2024-CMI-02440-1.pdf":
  drug_name: "Mounjaro"
  active_ingridients: ["Tirzepatide"]
